Spots Global Cancer Trial Database for A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
Official Title: A Multi-Center, Phase 1, Open-Label, Dose-Escalation Study of ABBV-428, an Immunotherapy in Subjects With Advanced Solid Tumors
Study ID: NCT02955251
Conditions
Study Description
Brief Summary: This is an open-label, Phase I, dose-escalation study to determine the recommended Phase 2 dose (RPTD), maximum tolerated dose (MTD), and evaluate the safety and pharmacokinetic (PK) profile of ABBV-428 when administered as monotherapy or in combination with nivolumab in participants with advanced solid tumors.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
HonorHealth Research Institute - Pima /ID# 155461, Scottsdale, Arizona, United States
UC Davis Comprehensive Cancer Center - Main /ID# 154439, Sacramento, California, United States
University of Chicago /ID# 154440, Chicago, Illinois, United States
Fox Chase Cancer Center /ID# 170665, Philadelphia, Pennsylvania, United States
Greenville Hospital System /ID# 154437, Greenville, South Carolina, United States
MD Anderson Cancer Center at Texas Medical Center /ID# 154441, Houston, Texas, United States
South Texas Accelerated Research Therapeutics /ID# 154442, San Antonio, Texas, United States
Chris O'Brien Lifehouse /ID# 163131, Camperdown, New South Wales, Australia
Northern Cancer Institute /ID# 163132, St Leonards, New South Wales, Australia
Institut Bergonie /ID# 202391, Bordeaux, Gironde, France
Institut Curie /ID# 162258, Paris CEDEX 05, Ile-de-France, France
Gustave Roussy /ID# 162257, Villejuif, Ile-de-France, France
Hopital de la Timone /ID# 162256, Marseille CEDEX 05, Provence-Alpes-Cote-d Azur, France
Centre Leon Berard /ID# 168072, Lyon CEDEX 08, Rhone, France
National Taiwan Univ Hosp /ID# 169034, Taipei City, Taipei, Taiwan
Contact Details
Name: AbbVie Inc.
Affiliation: AbbVie
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
